Preliminary Oral Sessions
CRISPR Medicine Conference 25 Preliminary Sessions
Following the remarkable success of our inaugural CRISPR Medicine Conference in 2024, we are delighted to present the preliminary programme for our 2025 edition. Building on the groundbreaking discussions and collaborations forged last year, this year's conference promises to further advance our understanding of gene-editing technology and its transformative potential in medicine.
This year's programme spans crucial developments in functional genomics and CRISPR screens, innovations in CRISPR and other gene-editing tools and gene-edited therapies, and both established and emerging delivery technologies. Special focus will be given to safety considerations and understanding genome editing outcomes, alongside the latest pre-clinical and clinical-stage strategies for treating human disease. Importantly, CRISPRMED25 will also address critical regulatory pathways and strategies to ensure patient access to these revolutionary therapies.
As we finalise the details, we invite you to explore this preliminary programme, which reflects both the field's most pressing challenges and its most promising opportunities. While some elements may be subject to adjustment, we are confident this programme will foster the same dynamic exchange of ideas that defined our inaugural event.
Explore the preliminary oral sessions below: